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Th is could represent an important fi nd-
ing if this genetic variant protects the 
fetus from impaired kidney development 
 in utero , particularly if the mother has 
a vitamin A defi ciency. However, this work 
provides only one piece of the puzzle in the 
search for causative genetic variants. 
 While one SNP in  ALDH1A2 was asso-
ciated with the two outcomes, 18 other 
SNPs in this gene were also genotyped. 
Furthermore, the authors considered 28 
SNPs in two other retinoic acid metabo-
lism genes ( CYP26A1 and  CYP26B1 ). One 
would expect two of the 47 SNPs to gener-
ate a  P value less than 0.05 by chance 
alone. But the same SNP was associated 
with two diff erent outcomes. Does that 
strengthen the inference? 
 Perhaps the deck was already stacked 
for such a fi nding. Imagine you are look-
ing for a weather-predicting coin. You 
have 47 coins (representing the SNPs) 
that you flip at midnight on 113 days 
(representing the subjects). Your aim is to 
see whether heads in one of the coins is 
associated with cloudy skies at 10  AM 
and rain in the next 24 hours. Just your 
luck, one of the coins is associated with 
both outcomes. However, the positive 
correlation between clouds and precipita-
tion tilts the odds in favor of such a fi nd-
ing — just as an association between 
retinoic acid and nephrogenesis may 
create dependency between the genetic 
association results. 
 In their discussion of the finding, 
El Kares  et al. 1 make a strong case for 
rs7169289 being a causative SNP for 
nephrogenesis: the SNP was associated 
with kidney volume in both of the 
RET 1476 subgroups, it is in a 3  Sp1 bind-
ing site, and the gene is important in 
retinoic acid metabolism. However, sim-
ilar arguments could be made for the 
other 46 SNPs tested — that is why those 
SNPs were selected to begin with. Th e 
associated SNP could also be in linkage 
disequilibrium with one or more truly 
causative SNPs. 
 A stringent correction for multiple test-
ing (such as a Bonferroni correction) 
requires that various associations being 
tested are independent. Th is may be true 
for genome-wide association studies that 
include thousands of SNPs not preselected 
for a particular function. However, when 
variants in  ‘ biologically plausible ’ genes are 
being examined, the usual Bonferroni cor-
rection is too conservative. Chapman and 
Whittaker have compared several proposed 
methods for examining multiple SNPs in a 
gene or region that maximize power while 
accounting for multiple testing. 2 Even with 
such methods, an individual researcher is 
facing an uphill battle when the number 
of SNPs is large and the sample size is 
relatively small. Replication is the best 
way to strengthen the causative interpre-
tation of such results, and El Kares  et al. 1 
have included the full results for all of 
their SNPs in supplemental tables to aid 
future researchers. 
 Another limitation is that fetal genetic 
polymorphisms are not the only determi-
nants of kidney development. Th e uterine 
environment is infl uenced not just by mater-
nal environmental exposures (including 
dietary intake), but also by the mother ’ s 
genetic variations. Unfortunately, separating 
the influence of the maternal and fetal 
genomes is diffi  cult, as mother and child 
share 50 % of their genes. Mother and child 
polymorphisms have usually been studied 
separately, but there are available methods 
for joint analysis in a case-control setting. 3,4 
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 Key mediators of cellular adaptation 
to hypoxia are hypoxia-inducible factors 
(HIFs), basic helix-loop-helix  transcription 
factors that consist of an oxygen-sensitive 
  -subunit and a constitutively expressed 
  -subunit, also known as the aryl hydro-
carbon receptor nuclear translocator 
(ARNT). HIFs regulate energy metabo-
lism, angiogenesis, erythropoiesis, cellular 
diff erentiation, extracellular matrix turn-
over, and other biological processes, 
primarily by transactivation of oxygen-
sensitive genes following binding to spe-
cifi c regulatory DNA sequences, so-called 
hypoxia-response elements. Increased 
HIF expression has been found in animal 
models of chronic kidney  disease (CKD) 
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 Hypoxia-inducible factors (HIFs) are oxygen-sensitive transcription 
factors that mediate cellular adaptation to hypoxia. Depending on the 
type of injury, activation of HIF signaling in renal cells may be 
renoprotective or promote fibrosis. Isoe and colleagues demonstrate 
that hyperglycemia activates HIF-1 in mesangial cells via carbohydrate 
response element binding protein (ChREBP), thus providing a novel link 
between alterations in systemic glucose homeostasis and HIF-regulated 
gene expression. 
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and in renal biopsy material from patients 
with diabetic nephropathy and other 
forms of renal disease. 1 – 3 Relative hypoxia, 
which is the major stimulus that causes 
HIF activation, can be detected in CKD 
tissues irrespective of etiology and is 
thought to result from a combination of 
structural and functional changes that 
include decreased peritubular blood fl ow 
associated with glomerular injury, capil-
lary rarefaction, vasoconstriction, lumi-
nal narrowing of atherosclerotic vessels, 
increased oxygen demand from hyper-
fi ltration and tubular hypertrophy, lim-
ited oxygen diff usion as a consequence 
of extracellular matrix expansion, and 
renal anemia. 1 HIF activation in this set-
ting has been shown to promote fi bro-
genesis and to negatively impact disease 
outcome on the basis of cell type- specifi c 
gene ablation studies. 2 Th ere are several 
possible mechanisms by which HIF may 
exert its profi brotic eff ect. Th ese include 
direct transcriptional regulation of gene 
products that control extracellular 
matrix turnover; functional cooperation 
with transforming growth factor-  1, a 
potent profi brotic factor; promotion of 
epithelial to mesenchymal transition; 
and modulation of renal infl ammation. 
In contrast to HIFs ’ profi brotic role in 
renal epithelial cells, there is experimen-
tal evidence in animal models that sys-
temic administration of cobalt chloride, 
possibly through HIF activation, is ben-
efi cial in diabetic nephropathy and other 
forms of CKD. 4,5 
 Although hypoxia is a major stimulus 
for HIF activation, stabilization of the 
oxygen-sensitive HIF   -subunit can occur 
in the absence of signifi cant hypoxia. Th is 
notion has signifi cant implications for the 
pathogenesis of renal injury, as activation 
of HIF responses could modulate disease 
activity at an early stage, when tissue oxy-
genation is not impaired. Classic examples 
of oxygen-independent HIF activation are 
inherited renal cancer syndromes, which 
are associated with genetic defects that 
result in an inability to degrade HIF-  —
 for example, von Hippel – Lindau disease 
and hereditary leiomyomatosis and renal 
cancer syndrome (HLRCC). 6 Normoxic 
HIF stabilization can also be achieved 
pharmacologically by inhibition of 
2 – oxoglutarate-dependent dioxygenases 
(prolyl-4 – hydroxylase domain (PHD) 
proteins), which function as intracellular 
oxygen sensors. PHDs hydroxylate spe-
cifi c proline residues within the oxygen-
dependent degradation domain of HIF-  , 
thus enabling interaction with the von 
Hippel – Lindau – E3 ubiquitin ligase 
complex, which in turn targets HIF-  for 
proteasomal degradation (reviewed by 
Kaelin and Ratcliff e 7 ). Several signaling 
molecules, some with key roles in the 
pathogenesis of CKD, have been shown to 
induce stabilization of HIF-  under nor-
moxia. Th ese include nitric oxide (NO), 
reactive oxygen species (ROS), tumor 
necrosis factor-  , interleukin-1, angio-
tensin II, and growth factors such as 
epidermal growth factor and insulin and 
insulin-like growth factors, which either 
inhibit HIF prolyl-hydroxylation 
directly or indirectly (for example, NO 
and ROS are direct inhibitors) or 
increase HIF-  levels through phos-
phatidylinositol-3-kinase-dependent 
mechanisms (growth factors). 
 Given the wide range of HIF-regulated 
biological functions, normoxic stabiliza-
tion of HIF-  is likely to modulate dis-
ease activity at an early stage before the 
occurrence of signifi cant hypoxia. An 
example of this is the stabilization of 
glomerular HIF-1  in the early phases of 
diabetic nephropathy in  db / db mice. 8 
Isoe and colleagues 9 (this issue) now 
identify a carbohydrate response element 
(ChRE) in the proximal  HIF1A promoter 
that regulates  HIF1A transcription in 
mesangial cells in response to glucose 
 in vitro and  in vivo ( Figure 1 ). Exposure 
of mesangial cells to high-glucose culture 
conditions or to hyperglycemia  in vivo 
resulted in increased  HIF1A (and also 
 EPAS1 / HIF2A ) transcription and HIF-1  
stabilization, which appeared to be inde-
pendent of PHD activity. Th is response, 
which is cell type-specific, as  HIF1A 
transcription cannot be induced in renal 
tubular epithelial cells, depends on the 
presence of carbohydrate response ele-
ment binding protein (ChREBP), which 
binds to the HIF-ChRE localized between 
nucleotides   −  254 and   −  243. ChREBP is 
a glucose-responsive basic helix-loop-
helix transcription factor of approxi-
mately 100  kDa, also termed MondoB or 
Williams – Beuren syndrome critical 
region gene 14 (WBSCR14), that dimer-
izes with Max-like protein X (Mlx) to 
transactivate glucose-sensitive genes, 
such as liver-type pyruvate kinase, fatty 
acid synthase, and acetyl-CoA carboxy-
lase 1. In the liver, ChREBP functions as 
a regulator of  de novo lipid synthesis in 
response to elevated serum glucose, irre-
spective of insulin levels. Its nuclear 
translocation is regulated by the forma-
tion of xylulose-5-phosphate and protein 
phosphatase 2A activity (reviewed by 
Uyeda and Repa 10 ) ( Figure 1 ). 
 A recent report indicates that ChREBP 
in pancreatic islet   -cells is a negative 
regulator of ARNT, the constitutively 
expressed   -subunit of HIF heterodim-
ers. 11 Th is fi nding predicts an impairment 
of HIF-mediated transcriptional responses 
under high-glucose conditions. Whether 
ARNT is also glucose-regulated in 
mesangial cells has not been investigated. 
Isoe and colleagues show that several 
genes known to be HIF targets, including 
 vascular endothelial growth factor ( VEGF ), 
 plasminogen activator inhibitor-1 ( PAI-1 ), 
 connective tissue growth factor ( CTGF ), 
 glucose transporter 1 ( GLUT-1 ),  hexoki-
nase 2 , and  adrenomedullin , are upregu-
lated in normoxic mesangial cells when 
cultured in high-glucose-containing 
medium. 9 Although the authors do not 
formally demonstrate that HIF-1 binds to 
the respective hypoxia-response elements 
using chromatin immunoprecipitation 
analysis, they found that interfering RNA 
directed against  HIF1A reduced  CTGF 
and  PAI-1 expression to control levels 
(expression levels under normal glucose 
conditions). ChREBP knock-down phe-
nocopied HIF-1  knock-down, support-
ing the notion that the ChREBP – HIF axis 
is responsible for the upregulation of these 
genes under high-glucose conditions. It is 
important to mention here that CTGF and 
PAI-1 are strong promoters of fi brosis, 
and further studies using genetic models 
are needed to investigate to what degree 
hyperglycemic activation of HIF-1 in 
mesangial cells contributes to the develop-
ment of diabetic glomerulopathy and 
matrix deposition. 
 Isoe  et al. 9 make the important obser-
vation that high glucose induces mesan-
gial  VEGF expression through presumed 
HIF-1 transactivation (the role of HIF-1 
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in its glucose-mediated induction is not 
directly examined), which not only has 
signifi cant implications for the pathoge-
nesis of diabetic nephropathy, but is also 
important for understanding HIF trans-
activation function in the setting of 
diabetes, which appears to be cell type-
dependent. In contrast, at least in the con-
text of hypoxia, HIF-mediated  VEGF 
induction in certain diabetic tissues has 
been shown to be impaired or absent. For 
example, dermal fi broblasts from diabetic 
patients fail to induce  VEGF under 
hypoxia, resulting in poor wound healing, 
and reduced tubulointerstitial  VEGF 
expression was found in renal biopsy 
material from patients with diabetic 
nephropathy and evidence of capillary 
rarefaction, which is associated with the 
presence of relative hypoxia. 12,13 The 
inability to induce  VEGF under hypoxic 
conditions in these settings may involve 
glucose-dependent alterations of HIF-  
protein stability 14 or may result from a 
covalent, methylglyoxal-based modifi ca-
tion of p300, a coactivator of HIF that 
interacts with the C-terminal transactiva-
tion domain, resulting in reduced tran-
scriptional activity and decreased VEGF 
levels. 12 Importantly, HIF-1  itself was 
found to be modifi ed by methylglyoxal, 
which reduces its ability to dimerize with 
ARNT, thereby negatively impacting HIF 
signaling. 15 Given these findings, it is 
likely that the mesangial HIF transcrip-
tional complex is also subject to similar 
hyperglycemia-induced protein modifi -
cations. Whether these changes aff ect 
the pattern of HIF-dependent glomeru-
lar gene expression, and to what degree 
they impact the pathogenesis of diabetic 
renal disease, remain to be defined. 
Interestingly, PHD3, a known HIF-1 tar-
get, does not respond to high glucose. 9 
PHD3 is a HIF prolyl-4-hydroxylase that 
is highly hypoxia-inducible and is 
involved in targeting HIF-  for degrada-
tion following reoxygenation. 7 Th e unre-
sponsiveness of PHD3 to high glucose 
indicates that hyperglycemia-induced 
expression of HIF targets is likely to 
 Figure 1  |  Glucose regulates  HIF1A transcription via ChREBP in mesangial cells . Under normoxia, HIF-1  is hydroxylated by prolyl-4-hydroxylases 
and targeted for proteasomal degradation by the pVHL – E3 ubiquitin ligase complex. When prolyl-4-hydroxylation is inhibited — for example, in the 
absence of molecular oxygen — HIF-1  is not degraded and translocates to the nucleus, where it heterodimerizes with the aryl hydrocarbon receptor 
nuclear translocator (ARNT). HIF-1  / ARNT heterodimers bind to the HIF consensus binding site, RCGTG, followed by transactivation of target genes. 
Nitric oxide, reactive oxygen species, the Krebs cycle metabolites succinate and fumarate, cobalt chloride, and iron chelators such as desferrioxamine 
inhibit HIF prolyl-4-hydroxylation in the presence of oxygen. In normoxic mesangial cells, hyperglycemia results in increased HIF-1  protein levels 
and increased expression of HIF-regulated genes (for example,  PAI-1 and  CTGF ) irrespective of oxygen levels. Increased glucose flux results in the 
conversion of glucose-6-phosphate to xylulose-5-phosphate by the hexose monophosphate shunt pathway. Xylulose-5-phosphate activates protein 
phosphatase 2A, which in turn dephosphorylates carbohydrate response element binding protein (ChREBP), allowing for its nuclear translocation. 
In mesangial cells ChREBP binds to the proximal  HIF1A promoter, stimulating its transcription. The proposed mechanism for ChREBP activation 
in mesangial cells is based on studies with hepatocytes. CBP, CREB-binding protein; CoCl 2 , cobalt chloride; CTGF, connective tissue growth factor; 
Fe 2  +   , ferrous iron; HMP, hexose monophosphate; Mlx, Max-like protein X; NO, nitric oxide; PAI-1, plasminogen activator inhibitor-1; PP2A, protein 
phosphatase 2A; ROS, reactive oxygen species. 
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involve additional regulatory mecha-
nisms that modulate HIF responses in a 
gene-dependent manner. 
 In summary, the study by Isoe and col-
leagues 9 provides novel insights into the 
regulation of HIF signaling in mesangial 
cells exposed to hyperglycemia and links 
systemic glucose homeostasis directly to 
HIF-dependent gene expression via 
ChREBP. Th e study also nicely illustrates 
that activation of HIF signaling can 
occur in the absence of significant 
hypoxia. Although a time course was not 
presented, the study by Isoe and col-
leagues 9 furthermore suggests that HIF 
activation can occur at an early stage 
during disease evolution before overt 
diabetic nephropathy is present. The 
pathogenetic role of early mesangial HIF 
activation in this setting, however, 
remains to be investigated. With regard 
to therapeutic intervention, inhibition 
of HIF for the treatment of diabetic 
nephropathy may not be feasible, given 
its role in the regulation of a wide spec-
trum of hypoxia responses, which include 
renal erythropoietin production and acti-
vation of certain renoprotective pathways. 
A more viable approach could be the 
pharmacologic targeting of specifi c HIF-
regulated gene products that have key 
roles in the pathogenesis of diabetic 
nephropathy. Th ere is certainly need for 
detailed genetic studies in rodents that 
examine cell type- and context-depend-
ent functions of HIF. Th ese studies will 
ultimately tell whether and to what degree 
glucose-induced activation of HIF signal-
ing in mesangial cells contributes to the 
pathogenesis of diabetic nephropathy. 
 DISCLOSURE 
 The author declared no competing interests. 
 ACKNOWLEDGMENTS 
 V.H.H. is supported by the Krick-Brooks Chair 
in Nephrology and by grants from the 
National Institutes of Health. 
 REFERENCES 
 1 .  Fine  LG ,  Norman  JT .  Chronic hypoxia as a 
mechanism of progression of chronic kidney 
diseases: from hypothesis to novel therapeutics . 
 Kidney Int  2008 ;  74 :  867 – 872 . 
 2 .  Higgins  DF ,  Kimura  K ,  Bernhardt  WM  et al.  Hypoxia 
promotes fibrogenesis  in vivo via HIF-1 stimulation 
of epithelial-to-mesenchymal transition .  J Clin 
Invest  2007 ;  117 :  3810 – 3820 . 
 3 .  Neusser  MA ,  Lindenmeyer  MT ,  Moll  AG  et al. 
 Human nephrosclerosis triggers a hypoxia-related 
glomerulopathy .  Am J Pathol  2010 ;  176 : 
 594 – 607 . 
 4 .  Ohtomo  S ,  Nangaku  M ,  Izuhara  Y  et al.  Cobalt 
ameliorates renal injury in an obese, hypertensive 
type 2 diabetes rat model .  Nephrol Dial Transplant 
 2008 ;  23 :  1166 – 1172 . 
 5 .  Tanaka  T ,  Matsumoto  M ,  Inagi  R  et al.  Induction 
of protective genes by cobalt ameliorates 
tubulointerstitial injury in the progressive Thy1 
nephritis .  Kidney Int  2005 ;  68 :  2714 – 2725 . 
 6 .  Haase  VH .  Hypoxia-inducible factors in the kidney . 
 Am J Physiol Renal Physiol  2006 ;  291 :  F271 – F281 . 
 7 .  Kaelin  Jr  WG ,  Ratcliffe  PJ .  Oxygen sensing by 
metazoans: the central role of the HIF hydroxylase 
pathway .  Mol Cell  2008 ;  30 :  393 – 402 . 
 8 .  Makino  H ,  Miyamoto  Y ,  Sawai  K  et al.  Altered gene 
expression related to glomerulogenesis and 
podocyte structure in early diabetic nephropathy 
of db/db mice and its restoration by pioglitazone . 
 Diabetes  2006 ;  55 :  2747 – 2756 . 
 9 .  Isoe  T ,  Makino  Y ,  Mizumoto  K  et al.  High glucose 
activates HIF-1-mediated signal transduction 
in glomerular mesangial cells through a 
carbohydrate response element binding protein . 
 Kidney Int  2010 ;  78 :  48 – 59 . 
 10 .  Uyeda  K ,  Repa  JJ .  Carbohydrate response element 
binding protein, ChREBP, a transcription factor 
coupling hepatic glucose utilization and lipid 
synthesis .  Cell Metab  2006 ;  4 :  107 – 110 . 
 11 .  Noordeen  NA ,  Khera  TK ,  Sun  G  et al.  Carbohydrate-
responsive element-binding protein (ChREBP) 
is a negative regulator of ARNT/HIF-1beta gene 
expression in pancreatic islet beta-cells .  Diabetes 
 2010 ;  59 :  153 – 160 . 
 12 .  Thangarajah  H ,  Yao  D ,  Chang  EI  et al.  The molecular 
basis for impaired hypoxia-induced VEGF 
expression in diabetic tissues .  Proc Natl Acad Sci 
USA  2009 ;  106 :  13505 – 13510 . 
 13 .  Lindenmeyer  MT ,  Kretzler  M ,  Boucherot  A  et al. 
 Interstitial vascular rarefaction and reduced VEGF-
A expression in human diabetic nephropathy . 
 J Am Soc Nephrol  2007 ;  18 :  1765 – 1776 . 
 14 .  Botusan  IR ,  Sunkari  VG ,  Savu  O  et al.  Stabilization 
of HIF-1alpha is critical to improve wound healing 
in diabetic mice .  Proc Natl Acad Sci USA  2008 ;  105 : 
 19426 – 19431 . 
 15 .  Ceradini  DJ ,  Yao  D ,  Grogan  RH  et al.  Decreasing 
intracellular superoxide corrects defective 
ischemia-induced new vessel formation in diabetic 
mice .  J Biol Chem  2008 ;  283 :  10930 – 10938 . 
